MAI Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,843
Closed -$16.6K 2272
2026
Q1
$16.6K Buy
4,843
+1,192
+33% +$4.02K ﹤0.01% 2900
2025
Q4
$10.3K Buy
3,651
+1,000
+38% +$5.16K ﹤0.01% 2830
2025
Q3
$18.5K Buy
2,651
+1,000
+61% +$7.05K ﹤0.01% 2435
2025
Q2
$9.77K Buy
1,651
+1,000
+154% +$5.75K ﹤0.01% 2742
2025
Q1
$4.16K Buy
+651
New +$6.28K ﹤0.01% 2779

Other funds holding ASPN

MAI Capital Management's ASPN Position: Q2 2026 in Review

MAI Capital Management sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 4,843 shares — an estimated $16.6K sold.

MAI Capital Management first reported a position in ASPN in Q1 2025 and held it in 5 quarters. The position peaked at $18.5K in Q3 2025. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • MAI Capital Management reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 4,843 Aspen Aerogels shares in Q2 2026, an estimated $16.6K.
  • MAI Capital Management first reported a position in Aspen Aerogels in Q1 2025 and held it in 5 quarters.
  • MAI Capital Management's Aspen Aerogels position peaked at $18.5K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.